Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Altusin Active Pharmaceutical Ingredient (API)

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Altusin

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 52Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    24/05/2024 Malladi Drugs & Pharmaceuticals Limited
    India
    		 M/s Malladi Drugs and Pharmaceuticals Limited WC-0364 Ephedrine Hydrochloride USP, BP, IP, EP 2021-02-26 2024-02-25 Unit-1, Plot No. 67, SIPCOT Industrial Complex, Ranipet, Vellore District, Tamil Nadu-632403 India
    01/01/2018 Avon Organics Limited
    India
    		 M/s Avon Organics Ltd WC-0221 Ephedrine HCI 2013-07-31 2016-07-02 E-2 MIDC Chincholi Solapur 413255 Maharashtra State